326 results on '"Oscier, D G"'
Search Results
2. Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
3. Longitudinal copy number, whole exome and targeted deep sequencing of ‘good risk’ IGHV-mutated CLL patients with progressive disease
4. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage
5. 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia
6. A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL
7. GENETIC AND PHENOTYPIC ATTRIBUTES OF SPLENIC MARGINAL ZONE LYMPHOMA
8. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR
9. P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12
10. Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B
11. Pharmacogenetic analysis of CYP2B6 in the LRF CLL4 trial: the *6 allelic variant is associated with inferior efficacy following fludarabine plus cyclophosphamide: 39
12. Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia
13. The significance of deletion architecture, ATM mutational status and genomic complexity in 11q deleted CLL: 29
14. Mutations in SF3B1, but not NOTCH1, are independently associated with survival in the UK CLL4 trial: 27
15. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations
16. Final response assessment of the CLL208 trial: an open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL).: 43
17. A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease
18. Predicting clinical outcome in early stage chronic lymphocytic leukaemia (CLL): A multi-centre study of 1153 patients: 39
19. Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69
20. Utility of early screening for JAK2 V617F mutation in patients with erythrocytosis or thrombocytosis in a District General Hospital: 235
21. HOX genes are a major target for epigenetic mis-regulation in adult and childhood leukaemia: 236
22. Guidelines on the management of Waldenström macroglobulinaemia
23. Novel technique to facilitate the rapid identification of CLL patients utilising the VH3-21 gene
24. Identification of a novel gene, GEMS, that is fused to FGFR1 in the 8p11 myeloproliferative syndrome
25. THE OPTIMAL MANAGEMENT OF POLYCYTHAEMIA VERA
26. THE MANAGEMENT OF 'LOW-RISK' AND 'INTERMEDIATE-RISK' PATIENTS WITH PRIMARY THROMBOCYTHAEMIA
27. Association of myelodysplastic changes with purine analogues
28. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12
29. Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia
30. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia
31. Karyotypic evolution in a granulocytic sarcoma developing in a myeloproliferative disorder with a novel (3;4) translocation
32. Immunoreactive Calcitonin In Leukaemia
33. Pyogenic Abscesses In The Myelodysplastic Syndrome
34. The significance of deletion architecture, ATM mutational status and genomic complexity in 11q deleted Chronic Lymphocytic Leukaemia
35. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
36. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
37. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial
38. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
39. SNP-Arrays Provide New Insights Into the Pathogenesis of Richter Syndrome
40. Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
41. ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
42. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage
43. ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele
44. Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial
45. 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia
46. Evolution of a terminal deoxynucleotidyl transferase-positive lymphoma from a chronic T cell lymphocytosis
47. A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease
48. HEPARIN-INDUCED THROMBOCYTOPENIA IN PREGNANCY
49. ZAP-70 by flow cytometry: A comparison of different antibodies, anticoagulants, and methods of analysis
50. Immunoglobulin V genes and CD38 expression in CLL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.